Image Credit: Health and me
There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.
The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.
While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.
Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.
While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.
Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.
Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.
RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.
Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.
The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.
Also Read: Is US Preparing For A Quad- demic 2025?
The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:
While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.
If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.
As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.
Credit: PIB
In yet another milestone in India’s digital healthcare, the government has launched the Swasth Bharat Portal, which aims to bring together the fragmented health systems in the country.
The portal, unveiled during the recent 10th National Summit on Innovation and Inclusivity by Union Minister for Health and Family Welfare JP Nadda, signifies a decisive shift towards a more integrated, efficient, and scalable digital public health architecture.
The portal aims to enable seamless integration with the Ayushman Bharat Digital Mission (ABDM) and support the exchange of patient records through the ABHA health account system.
The Swasth Bharat Portal has been conceptualized as an aggregator platform that integrates existing program systems through an API-based federated architecture.
It enables interoperability and convergence, creating a unified digital layer across programs.
It is a one-stop integrated platform that brings multiple national health programs onto a single interface.
It eliminates the need for multiple logins and repetitive data entry, and significantly reduces the administrative burden on healthcare providers while enhancing efficiency at all levels.
The portal also provides a single platform for easy access, along with data visualisation tools and the use of data at the local level for monitoring and evidence-based planning.
It is ABDM-compliant and supports integration with ABHA (Ayushman Bharat Health Account), enabling seamless and secure exchange of patient health records.
It is designed to evolve into a comprehensive and interoperable digital health ecosystem, further integrating with national registries such as the Healthcare Professionals Registry (HPR) and Health Facility Registry (HFR).
The new portal will help:
Read More: Medical Miracle: World First Frozen Testicular Implant Gives ‘Infertile’ UK Man Hope of Fatherhood
The Swasth Bharat portal will also lead to substantial government savings both in terms of human resources, time, and IT infrastructure as compared to the current individual portals being managed by different program divisions, the Health Ministry said.
Further, the portal enables a shift towards an integrated, efficient, and scalable digital public infrastructure with significant efficiency gains.
The Swasth Bharat Portal thus represents a transformative step towards convergence, efficiency, and data-driven governance in India’s public health system.
Researchers have just found that eggs should be eaten every day for lowering Alzheimer's disease risk. (Photo credit: AI generated)
Eggs are literally one of the healthiest foods on the planet. They offer proteins, healthy fats, vitamin D, choline, and other essential vitamins and minerals. Therefore, it is a no-brainer that eating eggs is associated with several health benefits—from weight management to a healthier heart to even diabetes management. And now, according to researchers at the Loma Linda University School of Public Health, eating eggs is associated with a lower risk of Alzheimer's disease as well. Alzheimer's is often diagnosed in people aged 65 years and above. Researchers have found that eating one egg a day for at least five days can reduce Alzheimer's risk by 27 per cent.
Experts at the Loma Linda University School of Public Health found that, as compared to people who never eat eggs, eating at least five servings of the high-protein food option can significantly reduce Alzheimer's risk. Furthermore, the study also noted that less frequent consumption of eggs can work wonders in helping to dodge memory loss and other cognitive health-related symptoms. Researchers in the study found that eating eggs one to three times a month can reduce the risk by 17 per cent, and eating two to four times a week reduced the risk by 20 per cent. The study was published in the Journal of Nutrition.
Eggs are a whole food, and that is because of the nutrients they offer and their subsequent benefits for overall health. They are also sources of essential nutrients that improve brain health—they offer choline, phosphatidylcholine, and acetylcholine—all of which are critical for synaptic function and memory. They are also sources of zeaxanthin and lutein, carotenoids that accumulate in brain tissues and are linked to lower oxidative stress and better cognitive performance. Eggs are sources of omega-3 fatty acids and phospholipids that constitute 30 per cent of the total egg lipids essential for neurotransmitter receptor function.
Researchers in the study said that their aim was to understand the relationship between modifiable dietary factors linked to Alzheimer's disease risk. Experts stated that they studied egg consumption in visible ways, for instance, eating them fried, scrambled, or boiled, or in hidden ways such as packaged or baked goods. Scientists emphasised that moderate intake of eggs is an important part of a balanced diet. Whether for breakfast, as a post-workout meal, or simply as a snack satisfying cravings, this versatile food option must find its way into your diet. And after years of research and studies (with more to come), it can be said that eggs are key to a healthy life now and even years later.
Credit: Reuters
Officials at the US Food and Drug Administration have blocked publication of several studies supporting the safety of widely used vaccines against COVID-19 and shingles in recent months, according to a spokesman for the Department of Health and Human Services (HHS).
While the studies found serious side effects to be very rare, the HHS said they were pulled over concerns about their conclusions. These withdrawals aim to limit access to vaccines, reflecting broader policy changes under US Health Secretary Robert F. Kennedy Jr., a staunch critic of vaccines.
"The studies were withdrawn because the authors drew broad conclusions that were not supported by the underlying data. The FDA acted to protect the integrity of its scientific process and ensure that any work associated with the agency meets its high standards," said Andrew Nixon, a spokesman for the HHS, which oversees the FDA, in an email to Reuters.
The last one year of Trump administration, along with Kennedy as the head of the HHS, saw significant cut in research funding for vaccine development. It also fueled doubt on vaccines, and blocked other information supporting their safety.
The list includes research on COVID vaccine effectiveness by scientists from the Centers for Disease Control and Prevention (CDC).
In October, the scientists were directed to withdraw two COVID vaccine studies that had been accepted for publication in medical journals. Further, in February, top FDA officials did not sign off on submitting abstracts about studies of Shingrix, a shingles vaccine, to a major drug safety conference.
“The design of that study fell outside the agency’s purview,” Nixon said on rejecting the shingles vaccine. He did not address a question about the Shingrix safety study, which found the vaccine to be safe.
Also read: Donald Trump’s 'Squirrel' Remark Fuels Debate Over Brain Health And Cognitive Tests
In June 2025, his office asked CDC staff members to delete from the agency’s website a 17-page summary supporting the safety of thimerosal, an additive largely removed from vaccines 25 years ago.
Further, in August, Kennedy called the journal Annals of Internal Medicine to “immediately retract” a large Danish study concluding that the vaccine additive aluminum salts were safe. However, the study was not retracted.
Recently, Dr. Jay Bhattacharya, who was serving as interim leader of the CDC, canceled the publication of a report concluding that the Covid vaccine sharply cut the odds of hospitalizations and emergency room visits last winter, saying the study had limitations.
“At a moment when public trust in institutions like the CDC is fragile, we cannot afford to lower our standards,” Dr. Bhattacharya wrote in an editorial about news coverage of his decision.
Read More: Medical Miracle: World First Frozen Testicular Implant Gives ‘Infertile’ UK Man Hope of Fatherhood
Last June, a CDC panel backed by Kennedy voted to remove the mercury-based preservative thimerosal from flu shots, despite long-standing clinical evidence of its safety.
In August 2025, the HHS said it would wind down nearly $500 million in mRNA vaccine development, canceling 22 federal projects overseen by the Biomedical Advanced Research and Development Authority (BARDA), a government-backed funding body.
Other vaccines, including flu and hepatitis A, were also removed from routine recommendations. He also directed the CDC to stop recommending the vaccine for healthy pregnant women and children.
© 2024 Bennett, Coleman & Company Limited